Hjem › Nyrekreft (nyrecellekarcinom) › Maryland
Kliniske studier for Nyrekreft (nyrecellekarcinom) i Maryland
17 studier for Nyrekreft (nyrecellekarcinom) søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Research Site, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05536141Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05155033Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- og 10 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #14, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- National Institutes of Health Clinical Center, Bethesda
- FMH James M Stockman Cancer Institute, Frederick
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
- NCI - Center for Cancer Research, Bethesda
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT04981509A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Johns Hopkins Hospital, Baltimore
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07293351Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UPMC Western Maryland, Cumberland
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06661720Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT00001238Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 18 til 72 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT02830724A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT04923178A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Greater Baltimore Medical Center ( Site 0145), Baltimore
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07227402Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 18 til 100 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT05665361Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
- Johns Hopkins University, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 21. jul. 2026 · NCT07062549A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
- Johns Hopkins University (Data Collection Only), Baltimore
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jun. 2026 · NCT06835972Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Johns Hopkins Hospital /ID# 254056, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 4. jun. 2026 · NCT04777994Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
RekruttererFase 2
Alder 18 til 120 · Alle kjønn · Oppdatert 30. mar. 2026 · NCT03786796Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.